Yorktown Management & Research CO Inc Emergent Bio Solutions Inc. Transaction History

Yorktown Management & Research CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$33.11 - $55.01 $271,502 - $451,082	-8,200 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$56.61 - $80.46 $215,118 - $305,748	3,800 Added 86.36%	8,200 $517,000
Q4 2018 Feb 08, 2019	SELL	$55.63 - $73.24 $89,008 - $117,183	-1,600 Reduced 26.67%	4,400 $261,000
Q2 2018 Aug 10, 2018	SELL	$48.33 - $55.64 $125,658 - $144,664	-2,600 Reduced 30.23%	6,000 $303,000
Q2 2017 Aug 11, 2017	BUY	N/A	8,600	8,600 $292,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $404M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

Stay updated on Yorktown Management & Research CO Inc with notifications on news.